![Inflammation is a novel target for therapeutic interventions in myeloid neoplasms – Uwe Platzbecker](https://oncodaily.com/pub/uploads/2023/07/Uwe-Platzbecker.jpeg)
Photo of Uwe Platzbecker from aml-hub.com
Jul 9, 2023, 09:28
Inflammation is a novel target for therapeutic interventions in myeloid neoplasms – Uwe Platzbecker
Inflammation is a novel target for therapeutic interventions in myeloid neoplasms. Specific subsets of LR-MDS may benefit and others may probably not. More work needed to better understand. Thanks to Marie Schneider, Clara Rolfs, Michael Cross and the entire MDS team!
For article: Click here
Jul 27, 2024, 19:56